Gene · 3913
NIH grants2,633
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1,261 to 1,280 of 2,633
Download this page as JSON| Grant | Title | LAMB2 papers | Newest fiscal year |
|---|---|---|---|
| R01HL128173 | Multiscale Modeling of Myelodysplastic Syndromes | 1 | 2019 |
| R01HL129823 | Systems Biology of Fibroblast Activation Following Myocardial Infarction | 1 | 2019 |
| R01HL132585 | Mechanosensors that detect and treat Lung Fibrosis | 1 | 2019 |
| R15GM131330 | A three dimensional bioprinting approach to mapping critical determinants of stem cell asymmetric divisions | 1 | 2019 |
| R21AR074523 | Targeting NAD metabolism to treat systemic sclerosis | 1 | 2019 |
| R21EB024889 | Engineered Airway Construct for Cystic Fibrosis Disease Modeling | 1 | 2019 |
| R21ES027123 | Germline transmission of epigenetic alterations to offspring induced by bisphenol A exposure | 1 | 2019 |
| R21ES028957 | Endocrine Disruptors, Ahr Signaling, and Placentation | 1 | 2019 |
| R21HD090371 | Comprehensive mapping of mouse testis cell types and spermatogenic stages by single-cell RNA sequencing | 1 | 2019 |
| R21LM012884 | Deep and Integrative Analysis of RNA Sequencing Data to Identify Pathogenesis Heterogeneity of Chronic Lung Disease | 1 | 2019 |
| R24DK090964 | Interrupting the Vicious Cycle of Obesity and Metabolic Syndrome | 1 | 2019 |
| R24DK106755 | Discovery of Pancreatic Signatures in Type 2 Diabetes Mellitus | 1 | 2019 |
| R24NS092940 | The Mayo GBM Xenograft National Resource | 1 | 2019 |
| R33AR073042 | Dissecting autoimmune cellular and molecular networks in vitiligo | 1 | 2019 |
| R33CA212973 | Measurement of Aberrant Protein Folds in Malignant Cells with Proteomics and Mass Spectrometry | 1 | 2019 |
| R33ES025673 | Imaging mitochondrial signaling in B-cells ectopically implanted in the eye | 1 | 2019 |
| R37AA015913 | CNS injury caused by HIV-1 and alcohol: Protective effects of CB2 activation | 1 | 2019 |
| R37NS047344 | Local circuitry mechanisms regulating adult hippocampal neurogenesis | 1 | 2019 |
| R56AG058655 | Characterization of protective roles of ApoE2 against aging and Alzheimer's disease | 1 | 2019 |
| R56AG061808 | Synaptic decline in retina as a predictor of Alzheimer's disease | 1 | 2019 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3913/grants?page=64